SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. on March 11, 2024, reporting events occurring on March 5, 2024. The registrant is incorporated in Delaware and its common stock trades on The NASDAQ Capital Market under the symbol "BSGM".
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, or margin data. However, it discloses a material liquidity and capitalization deficiency: the Company failed to meet the $5,000,000 minimum stockholders' equity initial listing requirement for The NASDAQ Capital Market.
Material Changes
- Delisting Notice: On March 5, 2024, Nasdaq notified the Company that it failed to regain compliance with the minimum bid price requirement ($1.00 per share) within the 180-day compliance period ending March 4, 2024.
- Equity Deficiency: The Company was deemed ineligible for a second 180-day compliance period because it does not meet the $5,000,000 minimum stockholders' equity requirement.
- Appeal Filed: On March 11, 2024, the Company submitted a request for a hearing before the Nasdaq Hearings Panel to appeal the delisting determination.
Outlook, Risks, and Management Commentary
Management is awaiting a determination from Nasdaq regarding the granting of a hearing. If granted, the Company must provide a plan to regain compliance. The filing explicitly states there can be no assurance that a hearing will be granted, that a favorable decision will be obtained, or that the Company will be able to regain compliance with other Nasdaq Listing Rules. Pending the conclusion of the appeal, the stock will continue to trade on the Nasdaq Capital Market.
Investor Verification Checklist
- Verify the status of the appeal request with the Nasdaq Hearings Panel.
- Confirm the Company's current stockholders' equity to assess the gap against the $5,000,000 requirement.
- Monitor the Company's stock price to determine if it has recovered above the $1.00 minimum bid price.
- Review any subsequent filings for the hearing date or a formal delisting notice.